Scientists have reported a major breakthrough in our understanding of inflammatory bowel disorder. It could lead to more effective treatments for conditions like Crohn's disease, a new study found.

A lthough some health conditions are spoken about with more nuance and understanding than in the past, inflammatory bowel ...

Researchers at the Icahn School of Medicine at Mount Sinai have made a significant discovery, identifying genetic connections between inflammatory bowel disease (IBD) and Parkinson's disease (PD).

Although several treatment options exist in the management of Crohn's disease, a patient-centered approach is integral amid ...

Difficult-to-treat IBD is prevalent among approximately a quarter of individuals with IBD in a tertiary care setting.

In a review of 32 mixed-type human studies, multinational researchers found a growing association between various classes of ...

Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.

An anti-TL1A monoclonal antibody called tulisokibart may help people with moderate to severe ulcerative colitis achieve ...

Advertisement Ulcerative colitis affects over 900,000 Americans and is a form of inflammatory bowel disease (IBD). The exact ...

Tulisokibart is a tumor necrosis factor (TNF)-like cytokine 1A (TL1A) monoclonal antibody with a different mechanism of ...

A three-day National Inflammatory Bowel Disease (IBD) Conference and the second roundtable meeting of the BRICS IBD Consortium, being organised by the Vizag Gut Club Association in collaboration with ...

Pseudopolyps ocurr due to the inflammation related to Crohn's disease or ulcerative colitis. Learn what pseudopolyps on ...